Discover 2,314 paid clinical trials in Oceanside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,314
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
for
Prostate Cancer, Prostatic Neoplasms
Location: Orange CA, Los Angeles CA, Phoenix AZ, Stanford CA,
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male
Age: 18+
Code: NCT06056830
Phase3, Recruiting
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
for
Relapsed or Refractory Multiple Myeloma
Location: Orange CA, Phoenix AZ, Rochester MN, Nashville TN,
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT06375044
Phase1, Recruiting
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Location: Orange CA, Palo Alto CA, Sacramento CA, Denver CO,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05118789
Phase1, Phase2, Recruiting
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
for
B-cell Malignancy, Chronic Lymphocytic Leukemia,
Location: Orange CA, Houston TX, Milwaukee WI, Chicago IL,
Sponsor: Carna Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05602363
Phase1, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Location: Orange CA, Stanford CA, Sacramento CA, Aurora CO,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05384626
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic Wounds
for
Open Wound, Wound Heal
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT05169814
Early_phase1, Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Orange CA, Los Angeles CA, Aurora CO, Spokane WA,
Sponsor: Tvardi Therapeutics, Incorporated
Sex: All
Age: 18+
Code: NCT05440708
Phase1, Phase2, Recruiting
A Study to Evaluate the Effect of Food on the Bioavailability of AJ201, and Safety, Tolerability, and Pharmacokinetics of AJ201 in Japanese and White Healthy Male Participants
for
Healthy Male Adults, Food Effect in Healthy Volunteers
Location: Los Alamitos CA
Sponsor: AnnJi Pharmaceutical Co., Ltd.
Sex: Male
Age: 18 - 55
Code: NCT07549919
Phase1, Recruiting
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Orange CA, Los Angeles CA, Salt Lake City UT, Vancouver,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06615479
Phase3, Recruiting
Evaluation of Fever Occurring in Labor in Patients Receiving Epidural Anesthesia
for
Fever
Location: Orange CA, Long Beach CA
Sponsor: MemorialCare
Sex: Female
Age: 18+
Code: NCT00326521
Recruiting
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
for
Solid Tumor
Location: Orange CA, Santa Monica CA, Gilbert AZ, Irving TX,
Sponsor: ImmunoGenesis
Sex: All
Age: 18+
Code: NCT06014502
Phase1, Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Orange CA, Duarte CA, Las Vegas NV, Seattle WA,
Sponsor: J-Pharma Co., Ltd.
Sex: All
Age: 18+
Code: NCT07265674
Phase3, Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
for
Lung Diseases, Interstitial
Location: Orange CA, Upland CA, Los Angeles CA, San Francisco CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06572384
Phase3, Recruiting
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer
Location: Orange CA, Bakersfield CA, Phoenix AZ, Queen Creek AZ,
Sponsor: Protara Therapeutics
Sex: All
Age: 18+
Code: NCT05951179
Phase2, Recruiting
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
for
Dry Eye Disease (DED)
Location: Murrieta CA, Newport Beach CA, Garden Grove CA,
Sponsor: Oculis
Sex: All
Age: 18+
Code: NCT07548632
Phase2, Phase3, Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
for
Focal Onset Seizures
Location: Orange CA, Downey CA, Los Angeles CA, Boise ID,
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT05716100
Phase3, Recruiting
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
for
Recurrent Pericarditis
Location: Orange CA, Salt Lake City UT, Seattle WA, Houston TX,
Sponsor: Zomagen Biosciences Ltd.
Sex: All
Age: 18 - 70+
Code: NCT06836232
Phase2, Recruiting
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Location: Orange CA, San Francisco CA, Salt Lake City UT,
Sponsor: Cabaletta Bio
Sex: All
Age: 6 - 70+
Code: NCT06154252
Phase2, Phase3, Recruiting
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
for
Schizophrenia, Autism-Related Irritability
Location: Anaheim CA, Chino CA, Culver City CA, Garland TX,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 5 - 17
Code: NCT07424404
Phase3, Recruiting
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies